MedCity News February 20, 2020

2019 was a year of continued growth of private equity investment in healthcare and it’s likely 2020 will provide more of the same, notwithstanding the uncertainty of the 2020 election and concerns over an eventual economic downturn.

By all accounts, 2019 was a year of continued robust healthcare M&A activity by private equity firms, significantly outpacing 2018. Private equity firms continued to deploy significant capital broadly across the healthcare industry during 2019 as demands to solve for industry inefficiencies, value-based payment models, and overall cost reduction all point toward private equity investment as an attractive option for healthcare businesses with aggressive growth strategies. In addition to the sustaining performance of the U.S. economy as a whole in 2019, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Investments, Physician, Post-Acute Care, Provider, Trends
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Avive scores $57M for portable cardiac arrest device

Share This Article